MedTrace Logo

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

NCT00665743 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-06-10

No results posted yet for this study

Summary

We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.

Conditions

Interventions

DRUG

PN400

naproxen 500 mg /esomeprazole 20 mg

DRUG

naproxen

naproxen 500 mg tablet

DRUG

naproxen

naproxen 500 mg

Sponsors & Collaborators

  • POZEN

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00665743 on ClinicalTrials.gov